O ver the centuries, diabetes mellitus-associated ischemic ulcers have driven physicians to continue to improve their skills in healing the ulcers to prevent devastating complications. 1 Unfortunately, extremity amputation still remains the outcome in many cases. The recent development of vascular progenitor cell (PC) transplantation aimed at enhancing angiogenesis and wound healing may, however, provide new hope in the treatment of this old ailment. 2, 3 In this issue of Circulation Research, Barcelos et al show in a murine diabetes mellitus model that topical transplantation of human fetal CD133 ϩ PCs significantly accelerates the healing of skin wounds on ischemic hind limbs. 4 Their data suggest that the reparative angiogenesis is mediated by the wingless (Wnt) signaling pathway.
The prominin-1 (PROM1)/CD133 gene encodes a pentaspan transmembrane glycoprotein expressed in a variety of stem cells, including hematopoietic stem cells, endothelial PCs (EPCs), and neuronal/glial stem cells. 5, 6 By suppressing further differentiation, PROM1 helps these cells maintain their stem cell properties. Mutations in PROM1 may result in retinitis pigmentosa, 7 and its overexpression is also associated with cancer formation. 8 In view of this cancer potential, overstimulation of CD133 ϩ cells may also lead to unwanted consequences. Additionally, that human fetal CD133 ϩ cells are not easily accessible makes this approach clinically impractical. Of importance, however, the gist of the work by Barcelos et al 4 is not in promoting the use of human fetal CD133 ϩ cells in common practice but, rather, in the enhancement of Wnt-dependent signaling in local endothelial cells (ECs) induced by PROM1/CD133 through a paracrine mechanism. This is supported by the success of CD133 ϩ cellconditioned medium (CCM) in producing CD133 ϩ -like effects. The capability of Wnt antagonists to prevent the CD133 ϩ CCM effects suggests a mediator role for Wnt signaling. The observation by Barcelos et al is supported by another recent report in Circulation Research describing a Wnt-dependent mechanism of EC differentiation from embryonic stem cells. 9 By conveying information from the cell surface to the nucleus, the Wnt signaling pathway regulates embryonic development and cell fate decisions. 10 On adhering to Frizzled (Fz) and low-density lipoprotein (LDL) receptor-related protein 5/6, Wnt ignites the canonical signaling pathway to deactivate the Axin/adenomatous polyposis coli/glycogen synthase kinase-3␤ complex. This acts to stabilize ␤-catenin by preventing its phosphorylation. 11 Some ␤-catenin is then able to enter the nucleus and interact with the T-cell factor (TCF) family of transcription factors to promote specific gene expression. The ␤-catenin and TCF interaction can be inhibited by forkhead box transcription factor subgroup O (FOXO) proteins, which compete with TCF for ␤-catenin. 12 Fortunately, the activity of both FOXO and glycogen synthase kinase-3␤ can be suppressed by phosphatidylinositol 3-kinase (PI3K)-Akt, another primary signaling pathway that may act synergistically with the Wnt canonical pathway. Here, the authors demonstrate that CD133 ϩ PCs can secrete vascular endothelial growth factor (VEGF)-A, which activates PI3K-Akt through the kinase insert domain receptor (also known as VEGF receptor 2) to directly inhibit FOXO. Additionally, the CD133 ϩ PC-released VEGF-A can stimulate local ECs to express Wnt proteins and ignite Wnt signaling (Figure) .
Although this approach may seem effective for stimulating angiogenesis, certain concerns remain. Besides VEGF-A, CD133 ϩ PCs release broad-spectrum interleukins (ILs) and other chemokines, which may elicit nonspecific inflammatory reactions. Successful inhibition of the reactive angiogenesis by VEGF-A-and IL-8 -neutralizing antibodies further indicates the inflammatory nature of the angiogenic response. 13 VEGF-and IL-8 -associated angiogenesis is also inducible by oxidized phospholipids, such as oxidized 1-palmitoyl-2arachidonoyl-sn-glycero-3-phosphorylcholine. 14 VEGFmediated angiogenesis often leads to the formation of premature capillaries with increased permeability. 15 Furthermore, IL-8 activation may contribute to atherosclerotic advancement, 16 worsening tissue perfusion. Fibroblast growth factor (FGF)2, whose participation in CD133 ϩ cell-related Wnt signaling is not discussed in the present study, is more closely related to compensatory vasculogenesis. 17 Because FGF2 and VEGF are both critical to tissue repair, 13 it is important to examine how diabetes mellitus modulates angiogenic activities regulated by these growth factors.
L5 is a highly negatively charged LDL circulating in patients with type 2 diabetes, with hypercholesterolemia, or who are smokers. 18 -21 In the absence of ex vivo oxidation, L5 induces EC apoptosis and inhibits EPC differentiation by disrupting FGF2 autoregulation via an FGF2-PI3K-Akt loop, mediated by the lectin-like oxidized LDL receptor-1. 18 -21 By inhibiting PI3K-Akt activation, L5 may offset the angiogenic effects of CD133 ϩ PCs (Figure) . In nondiabetic patients experiencing an acute myocardial infarction, there is often a surge of CD133 ϩ PCs, such a compensatory response is dampened in those with-type 2 diabetes. 22 Investigation of how L5 may contribute to PC insufficiency in diabetes is warranted. The mechanism of how L5 is produced in diabetes is still unclear but may involve adipocytic dysfunction. Wnt signaling also regulates adipocyte differentiation, 23 although its role in diabetes development is still controversial. 24 Recent studies suggest that Wnt signaling is regulated by microRNAs (miRs), adding an additional level of complexity to this system. Expression of miR-8 potently antagonizes Wnt signaling, both by inhibiting Wnt-Fz interaction on the plasma membrane and by reducing TCF protein intracellularly. 25 Additionally, miR-15a and miR-16-1 can also antagonize Wnt signaling, and reduction of these microRNAs promotes growth of prostate cancer cells. 26 Thus, the role of Wnt signaling in EC or vascular PC activity is not totally clear at this time, and uncontrolled stimulation of this pathway may invite dangerous consequences. These considerations, including how L5 may counteract the CD133 ϩ PC and Wnt interactions, are schematically summarized in the Figure. 
